Skip to main content
Top
Published in: Diabetology International 2/2017

01-06-2017 | Original Article

Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors

Authors: Yuko Murata, Yoshiki Kadoya, Shoichi Yamada, Tokio Sanke

Published in: Diabetology International | Issue 2/2017

Login to get access

Abstract

Aim

Diabetes mellitus is reported to be a risk factor for dementia. We evaluated the cognitive function in elderly diabetic patients and estimated the prevalence of patients with cognitive impairment and looked for any related clinical factors.

Subjects and methods

Using 281 elderly (65 years of age or older) Japanese patients with type 2 diabetes mellitus who were free of clinically evident cognitive impairment, we evaluated their cognitive function with the Mini Mental State Examination (MMSE).

Results

The MMSE score of all the participants was 27.3 ± 2.4 with 31.3% of them being in the abnormal range (tentatively defined normal range as having an MMSE score of 27–30). Multiple regression analysis disclosed that fasting serum non-esterified fatty acid (NEFA), estimated glomerular filtration ratio (eGFR) and insulin treatment were significantly related factors for the MMSE score, in addition to age and schooling history, which are extremely strong factors.

Conclusions

We revealed that approximately one-third of elderly type 2 diabetic patients who were free of clinically evident cognitive impairment had impaired cognitive function, demonstrating that the MMSE score was significantly correlated with fasting NEFA level, renal function, insulin treatment, age and schooling history.
Literature
1.
go back to reference Blesseis GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.CrossRef Blesseis GJ, Staekenborg S, Brunner E, et al. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5:64–74.CrossRef
2.
go back to reference Ohara T, Doi Y, Ninomiya T, et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology. 2011;77:1126–34. Ohara T, Doi Y, Ninomiya T, et al. Glucose tolerance status and risk of dementia in the community: the Hisayama study. Neurology. 2011;77:1126–34.
3.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–96.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–96.CrossRefPubMed
4.
go back to reference Anthony JC, LeResche L, Niaz U, et al. Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397–408.CrossRefPubMed Anthony JC, LeResche L, Niaz U, et al. Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patients. Psychol Med. 1982;12:397–408.CrossRefPubMed
5.
go back to reference Ebady SA, Arami MA, Shafigh MH. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract. 2008;82:305–9.CrossRefPubMed Ebady SA, Arami MA, Shafigh MH. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract. 2008;82:305–9.CrossRefPubMed
6.
go back to reference Yamazaki Y, Miwa T, Sakurai H, et al. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J. 2011;58:109–15.CrossRefPubMed Yamazaki Y, Miwa T, Sakurai H, et al. Clinical backgrounds and morbidity of cognitive impairment in elderly diabetic patients. Endocr J. 2011;58:109–15.CrossRefPubMed
7.
go back to reference Sanke H, Mita T, Yoshii H, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diab Res Clin Pract. 2014;106:465–73.CrossRef Sanke H, Mita T, Yoshii H, et al. Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus. Diab Res Clin Pract. 2014;106:465–73.CrossRef
8.
go back to reference Starkstein SE, Rabins PV, Berthier ML, et al. Dementia of depression among patients with neurological disorders and functional depression. J Neuropsychiatry Clin Neurosci. 1989;1:263–8.CrossRefPubMed Starkstein SE, Rabins PV, Berthier ML, et al. Dementia of depression among patients with neurological disorders and functional depression. J Neuropsychiatry Clin Neurosci. 1989;1:263–8.CrossRefPubMed
9.
go back to reference Meara J, Mitchelmore E, Hobson P. Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson’s disease and their carers in the community. Age Ageing. 1999;28:35–8.CrossRefPubMed Meara J, Mitchelmore E, Hobson P. Use of the GDS-15 geriatric depression scale as a screening instrument for depressive symptomatology in patients with Parkinson’s disease and their carers in the community. Age Ageing. 1999;28:35–8.CrossRefPubMed
10.
go back to reference Crane PK, Walker R, Hubbard, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540–8. Crane PK, Walker R, Hubbard, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540–8.
11.
go back to reference Rizzo MR, Marfella R, Barbieri M, et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33:2169–74. Rizzo MR, Marfella R, Barbieri M, et al. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients. Diabetes Care. 2010;33:2169–74.
12.
go back to reference Young SE, Mainous AG 3rd, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care. 2006;29:2688–93.CrossRefPubMed Young SE, Mainous AG 3rd, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care. 2006;29:2688–93.CrossRefPubMed
13.
go back to reference Matsuzaki T, Sasaki K, Tanizaki Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010;75:764–70.CrossRefPubMed Matsuzaki T, Sasaki K, Tanizaki Y, et al. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010;75:764–70.CrossRefPubMed
14.
go back to reference Li J, Wang YJ, Zhang M, et al. Chongqing Ageing Study Group. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485–91.CrossRefPubMed Li J, Wang YJ, Zhang M, et al. Chongqing Ageing Study Group. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology. 2011;76:1485–91.CrossRefPubMed
15.
go back to reference Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73:674–80.CrossRefPubMed Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73:674–80.CrossRefPubMed
16.
go back to reference Kawamura T, Umemura T, Hotta M. Cognitive impairment in diabetic patients: can diabetes control prevent cognitive decline. J Diabetes Investig. 2012;10:413–23.CrossRef Kawamura T, Umemura T, Hotta M. Cognitive impairment in diabetic patients: can diabetes control prevent cognitive decline. J Diabetes Investig. 2012;10:413–23.CrossRef
17.
go back to reference Kawamura T, Umemura T, Umegaki H, et al. Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: association with microinflammation. J Diabetes Investig. 2014;5:597–605.CrossRefPubMedPubMedCentral Kawamura T, Umemura T, Umegaki H, et al. Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: association with microinflammation. J Diabetes Investig. 2014;5:597–605.CrossRefPubMedPubMedCentral
18.
go back to reference Zhang JB, Geng N, Li ZG, et al. Biomarkers of renal function in type 2 diabetic patients with cognitive impairment. Neurosci Lett. 2016;610:19–23.CrossRefPubMed Zhang JB, Geng N, Li ZG, et al. Biomarkers of renal function in type 2 diabetic patients with cognitive impairment. Neurosci Lett. 2016;610:19–23.CrossRefPubMed
19.
go back to reference Umegaki H, Iimuro S, Shinozaki T, et al. Japanese Elderly Diabetes Intervention Trial Study Group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2012;12(Suppl 1):103–9. Umegaki H, Iimuro S, Shinozaki T, et al. Japanese Elderly Diabetes Intervention Trial Study Group. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: baseline data analysis of the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int. 2012;12(Suppl 1):103–9.
20.
go back to reference Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–72.CrossRefPubMedPubMedCentral Whitmer RA, Karter AJ, Yaffe K, et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–72.CrossRefPubMedPubMedCentral
21.
go back to reference Feil DG, Rajan M, Soroka O, et al. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc. 2011;59:2263–72.CrossRefPubMed Feil DG, Rajan M, Soroka O, et al. Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy. J Am Geriatr Soc. 2011;59:2263–72.CrossRefPubMed
22.
go back to reference Kalmijn S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging. 2000;4:202–7.PubMed Kalmijn S. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. J Nutr Health Aging. 2000;4:202–7.PubMed
23.
go back to reference Snigdha S, Astarita G, Piomelli D, et al. Effects of diet and behavioral enrichment on free fatty acids in the aged canine brain. Neuroscience. 2012;202:326–33.CrossRefPubMed Snigdha S, Astarita G, Piomelli D, et al. Effects of diet and behavioral enrichment on free fatty acids in the aged canine brain. Neuroscience. 2012;202:326–33.CrossRefPubMed
24.
go back to reference Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42:776–82.CrossRefPubMed Kalmijn S, Launer LJ, Ott A, et al. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Ann Neurol. 1997;42:776–82.CrossRefPubMed
25.
go back to reference Page KA, Williamson A, Yu N, et al. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes. 2009;58:1237–44.CrossRefPubMedPubMedCentral Page KA, Williamson A, Yu N, et al. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes. 2009;58:1237–44.CrossRefPubMedPubMedCentral
Metadata
Title
Cognitive impairment in elderly patients with type 2 diabetes mellitus: prevalence and related clinical factors
Authors
Yuko Murata
Yoshiki Kadoya
Shoichi Yamada
Tokio Sanke
Publication date
01-06-2017
Publisher
Springer Japan
Published in
Diabetology International / Issue 2/2017
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-016-0292-9

Other articles of this Issue 2/2017

Diabetology International 2/2017 Go to the issue